相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets
Caroline Gest et al.
CANCER LETTERS (2012)
Targeting the Insulin-like Growth Factor Axis for the Development of Novel Therapeutics in Oncology
Jin Gao et al.
CANCER RESEARCH (2012)
p53 Regulates insulin-like growth factor-I receptor gene expression in uterine serous carcinoma and predicts responsiveness to an insulin-like growth factor-I receptor-directed targeted therapy
Zohar Attias-Geva et al.
EUROPEAN JOURNAL OF CANCER (2012)
Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: A predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas
Irene Asmane et al.
EUROPEAN JOURNAL OF CANCER (2012)
BRCA1 is Expressed in Uterine Serous Carcinoma (USC) and Controls Insulin-Like Growth Factor I Receptor (IGF-IR) Gene Expression in USC Cell Lines
Keren Amichay et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2012)
OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Carol Aghajanian et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Targeting the Insulin Growth Factor and the Vascular Endothelial Growth Factor Pathways in Ovarian Cancer
Minghai Shao et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Heterodimerization of Glycosylated Insulin-Like Growth Factor-1 Receptors and Insulin Receptors in Cancer Cells Sensitive to Anti-IGF1R Antibody
Jun Gyu Kim et al.
PLOS ONE (2012)
Insulin-Like Growth Factors Promote Vasculogenesis in Embryonic Stem Cells
Stephanie M. Piecewicz et al.
PLOS ONE (2012)
被撤回的出版物: Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab (Retracted article. See vol. 107, pg. 2024, 2012)
A. Gualberto et al.
BRITISH JOURNAL OF CANCER (2011)
Dual IGF-I/II-Neutralizing Antibody MEDI-573 Potently Inhibits IGF Signaling and Tumor Growth
Jin Gao et al.
CANCER RESEARCH (2011)
Insulin-like growth factor-I receptor (IGF-IR) targeting with monoclonal antibody cixutumumab (IMC-A12) inhibits IGF-I action in endometrial cancer cells
Zohar Attias-Geva et al.
EUROPEAN JOURNAL OF CANCER (2011)
Common genetic variation within IGFI, IGFII, IGFBP-1, and IGFBP-3 and endometrial cancer risk
Monica McGrath et al.
GYNECOLOGIC ONCOLOGY (2011)
Insulin-like growth factor-I receptor inhibition by specific tyrosine kinase inhibitor NVP-AEW541 in endometrioid and serous papillary endometrial cancer cell lines
Zohar Attias-Geva et al.
GYNECOLOGIC ONCOLOGY (2011)
The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma
Erin R. King et al.
GYNECOLOGIC ONCOLOGY (2011)
Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk
Celeste Leigh Pearce et al.
HUMAN MOLECULAR GENETICS (2011)
Inhibitory effect of siRNA targeting IGF-1R on endometrial carcinoma
Shanrong Shu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Increase in Docetaxel-Resistance of Ovarian Carcinoma-Derived RMG-1 Cells with Enhanced Expression of Lewis Y Antigen
Fan Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Interactions between IGF-I, estrogen receptor-alpha (ER alpha), and ER beta in regulating growth/apoptosis of MCF-7 human breast cancer cells
Rhone A. Mendoza et al.
JOURNAL OF ENDOCRINOLOGY (2011)
Down-regulation of IGF-1R expression inhibits growth and enhances chemosensitivity of endometrial carcinoma in vitro
Shanrong Shu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
A Phase 3 Trial of Bevacizumab in Ovarian Cancer
Timothy J. Perren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Insulin-like Growth Factor: Current Concepts and New Developments in Cancer Therapy
Erin R. King et al.
Recent Patents on Anti-Cancer Drug Discovery (2011)
AMG 479, a Novel IGF-1-R Antibody, Inhibits Endometrial Cancer Cell Proliferation Through Disruption of the PI3K/Akt and MAPK Pathways
Albert Mendivil et al.
REPRODUCTIVE SCIENCES (2011)
The insulin-like growth factor-I receptor as an oncogene
Haim Werner et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2011)
The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study
L. R. Molife et al.
BRITISH JOURNAL OF CANCER (2010)
Insulin-like Growth Factor 2 Expression Modulates Taxol Resistance and Is a Candidate Biomarker for Reduced Disease-Free Survival in Ovarian Cancer
Gloria S. Huang et al.
CLINICAL CANCER RESEARCH (2010)
Insufficient evaluation of adverse events is not a proof of safety
L. G. Hemkens et al.
DIABETOLOGIA (2010)
Cervical Scrapes Levels of Insulin-like Growth Factor-II and Insulin-like Growth Factor Binding Protein 3 in Women with Squamous Intraepithelial Lesions and Cervical Cancer
M. -L. Serrano et al.
HORMONE AND METABOLIC RESEARCH (2010)
Plasma levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in women with cervical neoplasia
Si Won Lee et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2010)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Hyperactivation of the Insulin-like Growth Factor Receptor I Signaling Pathway Is an Essential Event for Cisplatin Resistance of Ovarian Cancer Cells
Niels Eckstein et al.
CANCER RESEARCH (2009)
Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk
Kathryn L. Terry et al.
CARCINOGENESIS (2009)
Clinical Development of Inhibitors of the Insulin-like Growth Factor Receptor in Oncology
Antonio Gualberto et al.
CURRENT DRUG TARGETS (2009)
Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden
J. M. Jonasson et al.
DIABETOLOGIA (2009)
Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
H. M. Colhoun
DIABETOLOGIA (2009)
The insulin receptor substrate-1: A biomarker for cancer?
Renato Baserga
EXPERIMENTAL CELL RESEARCH (2009)
Targeting the IGF1 axis in cancer proliferation
Ilan Bruchim et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
BMS-536924 sensitizes human epithelial ovarian cancer cells to the PARP inhibitor, 3-aminobenzamide
Marie-Claude Beauchamp et al.
GYNECOLOGIC ONCOLOGY (2009)
The metabolic syndrome, IGF-1, and insulin action
Yasumichi Arai et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
AMG 479, a fully human anti-insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells
Pedro J. Beltran et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions
A. Gualberto et al.
ONCOGENE (2009)
Clinical implications of insulin-like growth factor 1 system in early-stage cervical cancer
Y-F Huang et al.
BRITISH JOURNAL OF CANCER (2008)
Insulin-like growth factor axis and oncogenic human papillomavirus natural history
Tiffany G. Harris et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer
Marc J. Gunter et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
The Type 1 Insulin-Like Growth Factor Receptor Pathway
Meenali M. Chitnis et al.
CLINICAL CANCER RESEARCH (2008)
Targeting insulin-like growth factor 1 receptor in sarcomas
Katia Scotlandi et al.
CURRENT OPINION IN ONCOLOGY (2008)
Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer
John S. P. Yuen et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women
Ibrahim Serdar Serin et al.
GYNECOLOGICAL ENDOCRINOLOGY (2008)
Differential Expression of IGF-I and Insulin Receptor Isoforms in HPV Positive and Negative Human Cervical Cancer Cell Lines
M. -L. Serrano et al.
HORMONE AND METABOLIC RESEARCH (2008)
Gene expression changes in cervical squamous cell carcinoma after initiation of chemoradiation and correlation with clinical outcome
Ann H. Klopp et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
IGF and Insulin Receptor Signaling in Breast Cancer
Antonino Belfiore et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2008)
IGF-1 Receptor Inhibitors in Clinical Trials-Early Lessons
S. John Weroha et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2008)
Similarities and differences between insulin and IGF-I: Structures, receptors, and signalling pathways
Haim Werner et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2008)
Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor:: potential mechanistic involvement of Mdm2 and β-arrestin1
R. Vasilcanu et al.
ONCOGENE (2008)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
IGF-I in epithelial ovarian cancer and its role in disease progression
Jane Brokaw et al.
GROWTH FACTORS (2007)
IGF axis gene expression patterns are prognostic of survival in epithelial ovarian cancer
Dimitrios Spentzos et al.
ENDOCRINE-RELATED CANCER (2007)
Insulin-like growth factors and ovarian cancer risk: A nested case-control study in three cohorts
Shelley S. Tworoger et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Potential applications for circulating tumor cells expressing the insulin-like growth factor-I receptor
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2007)
Insulin-like growth factor 2 and its receptors (IGF 1R and IGF 2R/mannose 6-phosphate) in endometrial adenocarcinorna
Jasminka Pavelic et al.
GYNECOLOGIC ONCOLOGY (2007)
Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer
Laura Baglietto et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
The role of the IGF system in cancer growth and metastasis: Overview and recent insights
Amir Abbas Samani et al.
ENDOCRINE REVIEWS (2007)
Mechanisms of Disease: metabolic effects of growth hormone and insulin-like growth factor 1
Derek LeRoith et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2007)
Overexpression of the insulin-like growth factor I receptor and activation of the AKT pathway in hyperplastic endometrium
Adrienne S. McCampbell et al.
CLINICAL CANCER RESEARCH (2006)
A phase I dose-escalation study of weekly IMC-A12, a fully human insulin like growth factor-1 receptor (IGF-IR) IgG1 monoclonal antibody (Mab), in patients (pts) with advanced cancer
C. Higano et al.
EJC SUPPLEMENTS (2006)
A phase I trial incorporating the pharmacodynamic (PD) study of circulating tumour cells (CTC) of CP-751,871 (C), a monoclonal antibody against the insulin-like growth factor 1 receptor (IGF-1R), in combination with docetaxel (D) in patients (p) with advanced cancer
P. C. Fong et al.
EJC SUPPLEMENTS (2006)
IGF-1, IGFBP-3 and breast cancer risk in women:: The European Prospective Investigation into Cancer and Nutrition (EPIC)
S. Rinaldi et al.
ENDOCRINE-RELATED CANCER (2006)
Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II
Eva S. Schemhammer et al.
ENDOCRINE-RELATED CANCER (2006)
Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by αvβ3 integrin signaling
MR Shen et al.
CARCINOGENESIS (2006)
Insulin-like growth factor receptor I targeting in epithelial ovarian cancer
WH Gotlieb et al.
GYNECOLOGIC ONCOLOGY (2006)
Association between adiponectin, insulin resistance, and endometrial cancer
Pamela T. Soliman et al.
CANCER (2006)
The p53-family members p63 and p73 inhibit insulin-like growth factor-I receptor gene expression in colon cancer cells
I Nahor et al.
GROWTH HORMONE & IGF RESEARCH (2005)
Blocking insulin-like growth factor-I receptor as a strategy for targeting cancer
F Hofmann et al.
DRUG DISCOVERY TODAY (2005)
In vivo effects of the human type I insulin-like growth factor receptor antibody A12 on androgen-dependent and androgen-independent xenograft human prostate tumors
JD Wu et al.
CLINICAL CANCER RESEARCH (2005)
High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer
RA Sayer et al.
GYNECOLOGIC ONCOLOGY (2005)
Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1
A Mawson et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2005)
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis
AG Renehan et al.
LANCET (2004)
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification
SF Lax
VIRCHOWS ARCHIV (2004)
In vivo antitumor activity of NVP-AEW541 -: A novel, potent, and selective inhibitor of the IGF-IR kinase
C García-Echeverría et al.
CANCER CELL (2004)
Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms
EE Calle et al.
NATURE REVIEWS CANCER (2004)
Uterine serous and Grade 3 endometrioid carcinomas - Is there a survival difference?
DM Boruta et al.
CANCER (2004)
Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth
A Girnita et al.
CANCER RESEARCH (2004)
Serum levels of insulin-like growth factor-I, IGF-binding protein 1 and 3, and insulin and endometrial cancer risk
E Weiderpass et al.
BRITISH JOURNAL OF CANCER (2003)
A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer
A du Bois et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas
A Ouban et al.
HUMAN PATHOLOGY (2003)
BRCA1-Sp1 interactions in transcriptional regulation of the IGF-IR gene
S Abramovitch et al.
FEBS LETTERS (2003)
Insulin-like growth factor II in gynecological cancers: A preliminary study
SP Mathur et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2003)
Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer
SP Mathur et al.
GYNECOLOGIC ONCOLOGY (2003)
Endometrial cancer and the IGF system: A case-control study in Greece
E Petridou et al.
ONCOLOGY (2003)
Circulating levels of insulin-like growth factor-I and risk of ovarian cancer
A Lukanova et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
BRCA1 suppresses insulin-like growth factor-I receptor promoter activity: Potential interaction between BRCA1 and Sp1
SB Maor et al.
MOLECULAR GENETICS AND METABOLISM (2000)
分享论文
